Summary: In the CHALLENGE trial, published in 2025, patients offered three years of exercise support after surgery and chemotherapy had higher five-year disease-free survival. The findings apply to a specific patient group, and exercise was not used instead of cancer treatment.
After cancer treatment ends, patients face a long period of follow-up. The CHALLENGE trial examined the role of exercise during that period, testing a regularly supported program that went beyond simply advising people to move more.
Study details
Published in the New England Journal of Medicine on June 1, 2025, the trial involved 889 patients at 55 centers. They had undergone colon cancer surgery and completed additional postoperative chemotherapy 2–6 months earlier. About 90% had stage III disease; the remainder had high-risk stage II disease.
Patients were randomly assigned to two groups. One received health-education materials. The other received the same materials plus three years of tailored exercise and behavioral support. The program included aerobic activities such as brisk walking, with the aim of making activity sustainable in everyday life. Trial group’s explanation.
What was found
Estimated five-year disease-free survival was 80.3% in the exercise group and 73.9% in the education-only group, a difference of 6.4 percentage points. Here, disease-free survival means time without cancer recurrence, a new cancer or death from any cause. The outcome does not measure colon cancer recurrence alone. Explanation of the findings.
What does it mean
Random assignment reduces the influence of explanations based on more active people already being healthier. The findings suggest that exercise support after treatment could be an important part of care for suitable patients. They do not establish that a particular amount of walking will provide the same benefit for everyone. Evidence in context.
Limitations
Participants were well enough to take part in exercise. The findings cannot be directly extended to advanced cancers, other cancer types or all patients. Recruitment spanned 15 years. The exercise group also had more professional contact, so the contribution of that support cannot be fully separated.
Treatment and safety
Musculoskeletal adverse events occurred in 18.5% of the exercise group and 11.5% of the comparison group. Exercise plans should be developed with the care team, taking the patient’s condition and treatment effects into account. Exercise does not replace surgery, chemotherapy or follow-up care. American Cancer Society safety guidance.
Editor’s Note
I previously discussed the relationship between colon cancer and exercise in an Instagram video. One intriguing area is exerkines. Released by muscles and other tissues in response to exercise, these molecules carry signals between cells. Researchers are investigating how examples such as IL-7 and IL-15 relate to the immune system.
A small study examined these two molecules after treatment for colon or rectal cancer. However, it did not measure recurrence and found no statistically significant differences in changes in their levels between the exercise and control groups. The CHALLENGE trial discussed in this article, meanwhile, shows that structured exercise extends disease-free survival in certain patients with colon cancer.
Exerkines are one possible explanation for this benefit. However, these studies have not yet established that exerkines mediate it.
Gürkan Özkoç MD, FACS
Sources and access level
Courneya KS et al. Structured Exercise after Adjuvant Chemotherapy for Colon Cancer. NEJM, 2025;393:13–25. DOI: 10.1056/NEJMoa2502760. A full-text PDF copy of the original article and the linked institutional explanations were reviewed. Supplementary files were not included in this review. The research was published in 2025.
Cho E et al. Effects of aerobic exercise on body composition and exerkines in colorectal cancer survivors. Frontiers in Sports and Active Living, 2025;7:1579221. DOI: 10.3389/fspor.2025.1579221. Exerkine study cited in the editor’s note: the open-access full text was reviewed. Published June 26, 2025.
Keep this story
Feedback to the editor
Only the editor can read this; it is not a public comment. Do not include personal health information.
Sign in to send feedback